Progress and challenges in the adjuvant treatment of stage II and III colon cancers. - Wikidata - wikimedia - TriplyDB

Progress and challenges in the adjuvant treatment of stage II and III colon cancers.

Progress and challenges in the adjuvant treatment of stage II and III colon cancers.

http://www.wikidata.org/entity/Q37134442

about

Zinc-finger protein X-linked is a novel predictor of prognosis in patients with colorectal cancer.Gab2 is a novel prognostic factor for colorectal cancer patients The Relationship between Telomerase Activity and Clinicopathological Parameters in Colorectal Cancer: A Meta-Analysis.The role of microRNAs in colorectal cancer.Clinicopathological significance of SPC18 in colorectal cancer: SPC18 participates in tumor progression.Gab2 facilitates epithelial-to-mesenchymal transition via the MEK/ERK/MMP signaling in colorectal cancer Association of inflammation-related and microRNA gene expression with cancer-specific mortality of colon adenocarcinoma.Targeting Six1 by lentivirus-mediated RNA interference inhibits colorectal cancer cell growth and invasion.Upregulation of TSPAN12 is associated with the colorectal cancer growth and metastasis Non-coding RNAs Enabling Prognostic Stratification and Prediction of Therapeutic Response in Colorectal Cancer Patients.MiR-1260b inhibitor enhances the chemosensitivity of colorectal cancer cells to fluorouracil by targeting PDCD4/IGF1

P2860

Q33898743-06BEC253-9A40-43FC-9A4D-84F2FC9289E0 Q35632166-37F796F5-06F4-4130-A869-0A6AE3524B67 Q35953585-8C33AA8F-B144-4949-B82A-DBEF0975D11F Q36096641-14414898-9E1A-4433-AD68-351E6D3E9D19 Q36196750-827154BE-11D2-472A-98F0-C810A9BC2D6A Q36454371-2A983519-DE01-4E73-A9A2-C4074E03696D Q37350337-4F42689F-F99E-4252-B08E-E877AE53FADF Q37587365-28976DE2-E239-4D7B-A32B-25E438B86D11 Q37685314-0E4CC42E-76D2-4551-B8B9-F56571743194 Q38826546-F2915268-217B-4EDC-9386-21C7EC90BC6C Q57144441-57337E3B-944A-4B96-A25F-E021F6F7C29A

P2860

Progress and challenges in the adjuvant treatment of stage II and III colon cancers.

http://www.wikidata.org/entity/Q37134442

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on April 2008

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Progress and challenges in the adjuvant treatment of stage II and III colon cancers.

@en

Progress and challenges in the adjuvant treatment of stage II and III colon cancers.

@nl

type

label

Progress and challenges in the adjuvant treatment of stage II and III colon cancers.

@en

Progress and challenges in the adjuvant treatment of stage II and III colon cancers.

@nl

prefLabel

Progress and challenges in the adjuvant treatment of stage II and III colon cancers.

@en

Progress and challenges in the adjuvant treatment of stage II and III colon cancers.

@nl

P1433

Q37134442-82A2DB8B-B20B-47C4-AA7B-971103227937

P1476

Q37134442-86DB286B-45D8-478D-AE43-F1692E2EC061

P2093

Q37134442-BF78948B-5E91-41B8-A9E3-8515A9943FCA

Q37134442-D9A12D35-AEB9-442E-A959-C30899F15F3A

P2860

Q37134442-05A32204-7B57-4DD5-ABF6-F7C4989DF706

Q37134442-0E87C5FC-E795-4652-B84A-B71404A405E6

Q37134442-13EA8671-3A18-48C7-9042-406AA5C2CD95

Q37134442-15EA00DA-DC17-49AF-8E8D-4F11BDAAF62C

Q37134442-15F988C4-949D-4041-87C2-CB65B068F102

Q37134442-1DD9BC88-D15C-4E66-B93C-49254D8A368D

Q37134442-296B1B94-50A3-4F95-A9F2-4239400ABEEE

Q37134442-392355F7-22E5-40A4-AD79-5E0E00402CC1

Q37134442-4C2164F2-F88E-479A-97F1-28769AED6BF5

Q37134442-4F290FBF-6175-45F7-9CFA-E83557E8DEE0

P304

Q37134442-890D6AB6-412D-4F89-AC38-68F0EF18D2C5

P31

Q37134442-7D1E4A2E-A77F-4BE5-AF98-823817D04442

P356

Q37134442-8602D988-BBD7-4F11-A625-AEA0D0D46ABC

P433

Q37134442-E6E3814E-9AAD-44B8-BC03-4C879A86057F

P478

Q37134442-F3930953-6FA9-43A1-ACFD-752D17B7A832

P577

Q37134442-8BDA86E3-5B34-4F4A-B34B-8F51282635C4

P698

Q37134442-8A406CC6-85A6-40EE-86AD-6780CFC8ABDD

P356

14737140.8.4.595

P1433

Expert Review of Anticancer Therapy

P1476

Progress and challenges in the adjuvant treatment of stage II and III colon cancers.

@en

P2093

John R Zalcberg

http://www.w3.org/2001/XMLSchema#string

Yu Jo Chua

http://www.w3.org/2001/XMLSchema#string

P2860

Phase II trial of cetuximab in patients with refractory colorectal cancer that expresses the epidermal growth factor receptor.

Global cancer statistics, 2002

Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer

FOLFIRI followed by FOLFOX6 or the reverse sequence in advanced colorectal cancer: a randomized GERCOR study

Edrecolomab alone or in combination with fluorouracil and folinic acid in the adjuvant treatment of stage III colon cancer: a randomised study

Adjuvant 5FU plus levamisole in colonic or rectal cancer: improved survival in stage II and III

Cancer statistics, 2006

Oral capecitabine vs intravenous 5-fluorouracil and leucovorin: integrated efficacy data and novel analyses from two large, randomised, phase III trials

Disease-free survival versus overall survival as a primary end point for adjuvant colon cancer studies: individual patient data from 20,898 patients on 18 randomized trials.

End points for colon cancer adjuvant trials: observations and recommendations based on individual patient data from 20,898 patients enrolled onto 18 randomized trials from the ACCENT Group.

P304

595-604

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1586/14737140.8.4.595

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

8

http://www.w3.org/2001/XMLSchema#string

P577

2008-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

18402526

http://www.w3.org/2001/XMLSchema#string